[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Views 308
Citations 0
Correction
February 17, 2020

Errors in Text, Figures, and Author Affiliation

JAMA Neurol. 2020;77(4):527. doi:10.1001/jamaneurol.2020.0044

In the Original Investigation by Meyer et al, titled “Characterization of Alzheimer Disease Biomarker Discrepancies Using Cerebrospinal Fluid Phosphorylated Tau and AV1451 Positron Emission Tomography,” published online January 21, 2020,1 there were errors in the Abstract, the text of the article, Figures 1 and 2, and in the author affiliations list. In the “Main Outcomes and Measures” section of the Abstract, the first sentence should read “We compared tau-positive vs tau-negative groups as indicated by either modality or demographic and clinical variables, amyloid β–PET burden, and flortaucipir-PET binding across Braak stage–related ROIs.” In the “PET Image Processing” subsection of the Methods, both instances of the S in “FreeSurfer” should be capitalized. In the final sentence of the first paragraph of the CSF Measurements subsection of the Methods, “Cobas” should be capitalized. In Figure 1, the R2 value should be 0.26. In Figure 2, panel A should be labeled “APOE ε4 carriers,” panel C should be labeled “Aβ+ individuals” and have PET in superscript in all instances, and the y-axis for panel D should be labeled “Global Florbetapir SUVR.” Finally, in the author affiliations, Dr Pichet Binette’s name should be listed as “Pichet Binette” rather than “Binette.” This article was corrected online.

References
1.
Meyer  P-F, Pichet Binette A, Gonneaud J, Breitner JCS, Villeneuve S.  Characterization of Alzheimer disease biomarker discrepancies using cerebrospinal fluid phosphorylated tau and AV1451 positron emission tomography  [published online January 21, 2020].  JAMA Neurol. doi:10.1001/jamaneurol.2019.4749PubMedGoogle Scholar
×